Track topics on Twitter Track topics that are important to you
The global research antibodies market including reagents is projected to grow at a CAGR of 6.2%.
The research antibodies market including reagents is estimated to grow at a CAGR of 6.2% from 2017 to 2022, to reach USD 12.60 billion by 2022 from USD 9.33 billion in 2017. The increasing RD activities and expenditure in the life science industry, increasing funding for proteomics research drug discovery, and growing collaboration between industries and academic institutes are the major factors responsible for the growth of the market during the forecast period. However, the quality concerns over research antibodies with respect to research reproducibility, cost and time intensive antibody development processes, and the pricing pressures faced by prominent market players are the major challenges currently at play in the market.
The antibodies segment is expected to grow at the fastest rate during the forecast period.
By product, the research antibodies market including reagents is segmented into antibodies and reagents. The research antibodies segment is expected to register the highest CAGR during the forecast period owing to their high sensitivity, specificity, and affinity in various research reactions. Also, they are majorly used in proteomic research and drug development for identification, regulatory characterization, and discovery.
The pharmaceutical and biotechnological companies segment is expected to grow at the fastest rate during the forecast period.
On the basis of end user, the research antibodies market is segmented into pharmaceutical biotechnological companies, academic research institutes, and contract research organizations. The pharmaceutical biotechnological companies segment is expected to grow at the highest CAGR during the forecast period. This is primarily due to the increasing research in the fields of genomics and proteomics and the high uptake of researchspecific antibodies in the drug discovery and development process.
APAC to witness the highest growth during the forecast period.
Geographically, the global research antibodies market is segmented into North America, Europe, AsiaPacific, Latin America, and the Middle East Africa. In 2016, North America commanded a major share of the research antibodies market. However, AsiaPacific is expected to witness the highest growth during the forecast period. The significant growth of the AsiaPacific market is mainly attributed to the growing proteomics and genomics research increasing research funding, increasing investments by pharmaceutical and biotechnology companies, and growing awareness of personalized therapeutics.
Some of the prominent players in the research antibodies and reagents market include Thermo Fisher Scientific, Inc. U.S., Merck Group Germany, Abcam plc U.K., Becton, Dickinson and Company U.S., BioRad Laboratories, Inc. U.S., Cell Signaling Technology, Inc. U.S., Agilent Technologies, Inc. U.S., F. HoffmannLa Roche Ltd. Switzerland, Danaher Corporation U.S., GenScript U.S., PerkinElmer, Inc. U.S., Lonza Switzerland, and BioLegend, Inc. U.S..
The report analyzes the various types of research antibodies and reagents in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the research antibodies market for different segments such as product, technology, application, end user, and region. The report also includes an indepth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the belowmentioned five strategies for strengthening their market position.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the research antibodies market
Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the research antibodies market
Market Development: Comprehensive information about lucrative emerging markets by product, technology, application, end user, and region
Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the research antibodies market
Competitive Assessment: Indepth assessment of growth strategies, products, and manufacturing capabilities of leading players in the research antibodies market
Original Article: Research Antibodies Market by Product Antibodies Primary, SecondaryMouse, Rabbit, Reagents, Technology Western Blot, Flow Cytometry, Elisa, Immunoflourescence, Immunohistochemistry, Application, End User Global Forecast to 2022 [Report Updated: 07082017NEXT ARTICLE
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...